Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection.

Kalser MH, Ellenberg SS.

Arch Surg. 1985 Aug;120(8):899-903. Erratum in: Arch Surg 1986 Sep;121(9):1045.

PMID:
4015380
3.

Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.

Yeo CJ, Abrams RA, Grochow LB, Sohn TA, Ord SE, Hruban RH, Zahurak ML, Dooley WC, Coleman J, Sauter PK, Pitt HA, Lillemoe KD, Cameron JL.

Ann Surg. 1997 May;225(5):621-33; discussion 633-6.

4.

Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.

Morak MJ, van der Gaast A, Incrocci L, van Dekken H, Hermans JJ, Jeekel J, Hop WC, Kazemier G, van Eijck CH.

Ann Surg. 2008 Dec;248(6):1031-41. doi: 10.1097/SLA.0b013e318190c53e.

PMID:
19092348
5.

Adjuvant therapy in pancreatic cancer: a critical appraisal.

Oettle H, Neuhaus P.

Drugs. 2007;67(16):2293-310. Review.

PMID:
17983252
6.

Survival after attempted surgical resection and intraoperative radiation therapy for pancreatic and periampullary adenocarcinoma.

O'Connor JK, Sause WT, Hazard LJ, Belnap LP, Noyes RD.

Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1060-6.

PMID:
15978737
7.

Neoadjuvant therapy for unresectable pancreatic adenocarcinoma.

Jessup JM, Steele G Jr, Mayer RJ, Posner M, Busse P, Cady B, Stone M, Jenkins R, Osteen R.

Arch Surg. 1993 May;128(5):559-64.

PMID:
8098206
8.

Postoperative chemoradiotherapy of pancreatic cancer: what is the appropriate target volume of radiation therapy?

Kim K, Kim S, Chie EK, Kim SW, Bang YJ, Ha SW.

Tumori. 2005 Nov-Dec;91(6):493-7.

PMID:
16457148
9.

Clinical experience with chronomodulated infusional 5-fluorouracil chemoradiotherapy for pancreatic adenocarcinoma.

Keene KS, Rich TA, Penberthy DR, Shepard RC, Adams R, Jones RS.

Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):97-103.

PMID:
15850908
10.

Adjuvant therapy following resection for pancreatic adenocarcinoma.

Brennan MF.

Surg Oncol Clin N Am. 2004 Oct;13(4):555-66, vii. Review.

PMID:
15350934
11.

Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.

Link KH, Leder G, Formentini A, Fortnagel G, Kornmann M, Schatz M, Beger HG.

Gan To Kagaku Ryoho. 1999 Jan;26(1):10-40. Review.

PMID:
9987495
12.
13.

Improved survival and local control after intraoperative radiation therapy and postoperative radiotherapy: a multivariate analysis of 46 patients undergoing surgery for pancreatic head cancer.

Alfieri S, Morganti AG, Di Giorgio A, Valentini V, Bossola M, Trodella L, Cellini N, Doglietto GB.

Arch Surg. 2001 Mar;136(3):343-7.

PMID:
11231859
14.

A multicenter randomized controlled trial to evaluate the effect of adjuvant cisplatin and 5-fluorouracil therapy after curative resection in cases of pancreatic cancer.

Kosuge T, Kiuchi T, Mukai K, Kakizoe T; Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer (JSAP)..

Jpn J Clin Oncol. 2006 Mar;36(3):159-65.

PMID:
16490736
16.

Preoperative chemoradiation for patients with locally advanced adenocarcinoma of the pancreas.

White R, Lee C, Anscher M, Gottfried M, Wolff R, Keogan M, Pappas T, Hurwitz H, Tyler D.

Ann Surg Oncol. 1999 Jan-Feb;6(1):38-45.

PMID:
10030414
17.

The case for routine use of adjuvant therapy in pancreatic cancer.

Kennedy EP, Yeo CJ.

J Surg Oncol. 2007 Jun 1;95(7):597-603. Review.

PMID:
17230543
19.

Review of adjuvant radiochemotherapy for resected pancreatic cancer and results from Mayo Clinic for the 5th JUCTS symposium.

Miller RC, Iott MJ, Corsini MM.

Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):364-8. doi: 10.1016/j.ijrobp.2008.11.069. Review.

PMID:
19735864
20.

Does intraoperative radiation therapy improve local tumor control in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma? A propensity score analysis.

Showalter TN, Rao AS, Rani Anne P, Rosato FE, Rosato EL, Andrel J, Hyslop T, Xu X, Berger AC.

Ann Surg Oncol. 2009 Aug;16(8):2116-22. doi: 10.1245/s10434-009-0498-1.

PMID:
19437078

Supplemental Content

Support Center